Literature DB >> 19617444

The mineralocorticoid receptor and its coregulators.

Jun Yang1, Morag J Young.   

Abstract

The mineralocorticoid receptor (MR) is a member of the nuclear receptor superfamily and is essential for controlling sodium transport in epithelial tissues such as the kidney and colon. Moreover, it is also present in other non-epithelial tissues and is capable of activation by both mineralocorticoids and glucocorticoids. A challenge in understanding transcriptional regulation by the MR and other nuclear receptors is to determine how tissue- and ligand-specificity is achieved. Over the past decade, it has become clear that a heterogeneous group of non-receptor proteins termed as coregulators are required to either enhance or repress nuclear receptor-mediated transactivation of target genes. A subset of these coregulators may be expected to confer specificity to MR-mediated responses by virtue of their variable tissue expression and selectivity for different ligands. Specific coregulator-MR interactions may be a suitable target in the rational design of tissue-specific MR modulators as has been described for other steroid receptors. However, the number of coregulators identified to date for the MR is very limited compared with other nuclear receptors. Understanding the full complement of MR coregulators is essential for unraveling the complexity of MR signaling pathways and will facilitate the development of selective MR modulators.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19617444     DOI: 10.1677/JME-09-0031

Source DB:  PubMed          Journal:  J Mol Endocrinol        ISSN: 0952-5041            Impact factor:   5.098


  26 in total

Review 1.  Enzymatic intracrine regulation of white adipose tissue.

Authors:  David DiSilvestro; Jennifer Petrosino; Ayat Aldoori; Emiliano Melgar-Bermudez; Alexandra Wells; Ouliana Ziouzenkova
Journal:  Horm Mol Biol Clin Investig       Date:  2014-07

2.  Mineralocorticoid receptor antagonizes Dot1a-Af9 complex to increase αENaC transcription.

Authors:  Xi Zhang; Qiaoling Zhou; Lihe Chen; Stefan Berger; Hongyu Wu; Zhou Xiao; David Pearce; Xiaodong Zhou; Wenzheng Zhang
Journal:  Am J Physiol Renal Physiol       Date:  2013-09-11

3.  Mineralocorticoid receptors are present in skeletal muscle and represent a potential therapeutic target.

Authors:  Jessica A Chadwick; J Spencer Hauck; Jeovanna Lowe; Jeremiah J Shaw; Denis C Guttridge; Celso E Gomez-Sanchez; Elise P Gomez-Sanchez; Jill A Rafael-Fortney
Journal:  FASEB J       Date:  2015-07-15       Impact factor: 5.191

4.  Lysine deacetylase inhibition attenuates hypertension and is accompanied by acetylation of mineralocorticoid receptor instead of histone acetylation in spontaneously hypertensive rats.

Authors:  Young Mi Seok; Hae Ahm Lee; Kwon Moo Park; Mi-Hyang Hwangbo; In Kyeom Kim
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-04-22       Impact factor: 3.000

Review 5.  Regulation of αENaC transcription.

Authors:  Lihe Chen; Xi Zhang; Wenzheng Zhang
Journal:  Vitam Horm       Date:  2015-02-14       Impact factor: 3.421

Review 6.  The multifaceted mineralocorticoid receptor.

Authors:  Elise Gomez-Sanchez; Celso E Gomez-Sanchez
Journal:  Compr Physiol       Date:  2014-07       Impact factor: 9.090

7.  Glucocorticoids Induce Cardiac Fibrosis via Mineralocorticoid Receptor in Oxidative Stress: Contribution of Elongation Factor Eleven-Nineteen Lysine-Rich Leukemia (ELL).

Authors:  Yosuke Omori; Toshiaki Mano; Tomohito Ohtani; Yasushi Sakata; Yasuharu Takeda; Shunsuke Tamaki; Yasumasa Tsukamoto; Takeshi Miwa; Kazuhiro Yamamoto; Issei Komuro
Journal:  Yonago Acta Med       Date:  2014-10-15       Impact factor: 1.641

8.  Myeloid cells are capable of synthesizing aldosterone to exacerbate damage in muscular dystrophy.

Authors:  Jessica A Chadwick; Sarah A Swager; Jeovanna Lowe; Steven S Welc; James G Tidball; Celso E Gomez-Sanchez; Elise P Gomez-Sanchez; Jill A Rafael-Fortney
Journal:  Hum Mol Genet       Date:  2016-12-01       Impact factor: 6.150

9.  Gene expression effects of glucocorticoid and mineralocorticoid receptor agonists and antagonists on normal human skeletal muscle.

Authors:  Jessica A Chadwick; J Spencer Hauck; Celso E Gomez-Sanchez; Elise P Gomez-Sanchez; Jill A Rafael-Fortney
Journal:  Physiol Genomics       Date:  2017-04-21       Impact factor: 3.107

10.  NF-YC functions as a corepressor of agonist-bound mineralocorticoid receptor.

Authors:  Ayano Murai-Takeda; Hirotaka Shibata; Isao Kurihara; Sakiko Kobayashi; Kenichi Yokota; Noriko Suda; Yuko Mitsuishi; Rie Jo; Hirochika Kitagawa; Shigeaki Kato; Takao Saruta; Hiroshi Itoh
Journal:  J Biol Chem       Date:  2010-01-06       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.